BIO-TECHNE Corp
TECH- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000842023
No open-market purchases or sales by BIO-TECHNE Corp insiders were filed in the last 90 days; 601 institutions reported holding it in 13F filings for Q2 2026, worth $12.3B in total; 3 superinvestors hold it, including Maverick Capital and Weitz Investment Management.
Holders of 5% or more of TECH
Holders whose latest Schedule 13D or 13G filing reports 5% or more of BIO-TECHNE Corp, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 13G | 7.38%11.6M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 7.00%11.0M shares | – | Oct 21, 20243 filings | Jul 16, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
23 Schedule 13D and 13G filings on BIO-TECHNE Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 20261:10 PM ET | FMR LLCand 1 other | 13G/A | 0.70%1.09M shares | −7.40 ppfrom 8.10%Below 5% | Sep 30, 2026 | SEC |
| Aug 6, 202610:17 AM ET | FMR LLCand 1 other | 13G/A | 8.10%12.8M shares | +3.10 ppfrom 5.00% | Jun 30, 2026 | SEC |
| May 6, 202611:00 AM ET | FMR LLCand 1 other | 13G | 5.00%7.86M shares | New | Mar 31, 2026 | SEC |
| Apr 29, 20265:00 PM ET | Vanguard Capital Management LLC | 13G | 7.38%11.6M shares | New | Mar 31, 2026 | SEC |
| Mar 26, 20264:10 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Nov 14, 202512:19 PM ET | Price T Rowe Associates Inc | 13G/A | 2.20%3.35M shares | −3.40 ppfrom 5.60%Below 5% | Sep 30, 2025 | SEC |
| Aug 14, 20251:07 PM ET | Price T Rowe Associates Inc | 13G/A | 5.60%8.85M shares | −1.60 ppfrom 7.20% | Jun 30, 2025 | SEC |
| Jul 16, 20257:02 PM ET | BlackRock, Inc. | 13G/A | 7.00%11.0M shares | – | Jun 30, 2025 | SEC |
| May 14, 202510:45 AM ET | Price T Rowe Associates Inc | 13G/A | 7.20%11.4M shares | – | Mar 31, 2025 | SEC |
| Nov 14, 2024 | Price T Rowe Associates Inc | 13GOld format | – | New | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Oct 21, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 24, 20249:46 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 26, 20238:52 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 20, 20239:43 AM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 9, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 27, 202211:00 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 25, 20223:03 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Sep 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 26, 20216:52 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
13 notices from officers, directors and other affiliates planning to sell BIO-TECHNE Corp shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| May 8, 20264:23 PM ET | Joshua MolhoDirector | 6.64K | $320.4K | May 8, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 17, 20264:19 PM ET | Joshua MolhoDirector | 1.98K | $116.8K | Feb 17, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 25, 20254:05 PM ET | Roeland NusseDirector | 17.0K | $960.4K | Aug 25, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 25, 20254:04 PM ET | Robert V. BAUMGARTNER4731 Bonita Bay BoulevardDirector | 17.0K | $957.8K | Aug 25, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 9, 20254:19 PM ET | Joshua MolhoOfficer | 1.28K | $63.7K | Jun 9, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 14, 20254:08 PM ET | Joshua MolhoDomestic Partner of Director | 1.86K | $122.7K | Feb 14, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 27, 20254:24 PM ET | Kim KeldermanDirector · Officer | 13.4K | $1.03M | Jan 27, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 8, 20244:13 PM ET | Robert V. BaumgartnerDirector | 16.0K | $1.15M | Aug 8, 2024 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 14, 20244:10 PM ET | John L HigginsDirector | 4.00K | $335.4K | May 14, 2024 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 7, 20243:03 PM ET | Nusse RoelandDirector | 10.4K | $800.6K | Mar 7, 2024 | Charles Schwab Corp. | SEC |
| Aug 30, 20234:14 PM ET | Roeland NusseDirector | 8.94K | $718.0K | Aug 30, 2023 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 21, 20234:34 PM ET | Kummeth Charles R.Officer | 80.0K | $7.07M | Jul 21, 202310b5-1 | UBS Financial Services, Inc. | SEC |
| Jun 6, 20232:29 PM ET | Charles KummethOfficer | 50.0K | $4.15M | Jun 6, 2023 | UBS Financial Services Inc | SEC |